Error in the Byline

• August 27, 2026

Population-Level Outcomes for Screening Program Cancers in First Nations People in Ontario, Canada

• by Amanda J. Sheppard, Rinku Sutradhar, Ning Liu, Alethea Kewayosh, Sayna Leylachian, Laura Senese, Andrea Ianni, Sarah Hyett, Anna M. Chiarelli, Rachel Kupets, C. Martin Tammemägi, Jill Tinmouth

• July 10, 2026

Novel Treatment Combination Improves Progression-Free Survival in Most Common Form of Metastatic Breast Cancer

Patients with estrogen-receptor-positive (ER+) HER-2-negative advanced breast cancer experienced significantly improved progression-free survival (PFS) when treated with an oral combination regimen that included giredestrant, a novel, next-generation selective ER degrader and full antagonist (SERD), compared to a standard combination approach.

• by

• October 1, 2026

• 4 min

When Historical Housing Policy Shapes Modern Breast Cancer Prevention

• by Laura C. Pinheiro, Kelly M. Kenzik

• September 2, 2026